Purchase Order 36C24621P0017
Award Date 10/1/20
Potential Completion Date 9/30/25
Potential Value $616K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Port Chester, NY 10573, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded a $669,668.17 firm fixed-price purchase order to Cytopath Biopsy Lab Inc. (doing business as Cblpath) for ThyroSeq V3 Classifier CPT molecular diagnostic testing services. The contract was awarded on August 5, 2024, with an ultimate completion date of August 5, 2029, and will be performed at the contractor's facility in Port Chester, New York. This award does not utilize a small business...
- This contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, is for the provision of ThyroSeq Genomic Classifier Tests. The $70,000.00 firm fixed price contract was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA) on October 1, 2024, with a period of performance through September 30, 2025. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with extensive experience...
- The Department of Veterans Affairs Veterans Integrated Service Network 10 (VISN 10) awarded a $146,250 firm fixed-price purchase order to Cytopath Biopsy Lab Inc. (operating as Cblpath) for ThyroSeq V3 Genomic Classifier (GC) testing services. The contract, awarded on December 29, 2025, with an ultimate completion date of December 28, 2026, will be performed at the Cleveland, OH location. This contract continues Cblpath's established role as a specialized provider of molecular diagnostic testing...
- The Department of Veterans Affairs Veterans Integrated Service Network 22 awarded a firm fixed-price purchase order valued at $2.31M to Cytopath Biopsy Lab Inc. (doing business as Cblpath) for ThyroSeq molecular diagnostic testing services. Under this contract, Cblpath will provide approximately 225 tests annually to multiple VA healthcare facilities within VISN 22, with interpretive reports to be delivered within 14 days of testing. The ThyroSeq test analyzes genetic mutations in thyroid...
- The Department of Veterans Affairs, Veterans Integrated Service Network 8, awarded a $288,000 firm fixed-price delivery order to Cytopath Biopsy Lab Inc. (doing business as Cblpath) on February 1, 2025, for ThyroSeq molecular diagnostic testing services. The contract, which has no set-aside designation, is scheduled for completion by January 31, 2026, with services to be performed in Port Chester, New York. ThyroSeq is a proprietary genetic testing service that analyzes mutations in thyroid...
- Cytopath Biopsy Lab Inc., operating as Cblpath, has been awarded a $33,750 firm fixed-price BPA call by Veterans Integrated Service Network (VISN) 6 for ThyroSeq genomic testing services. The contract, awarded on October 1, 2025, will be performed in Hampton, Virginia, with a completion date of September 30, 2026. This award represents a task order under a larger Blanket Purchase Agreement valued at $2.25 million that VISN 6 established with the contractor for thyroid genomic testing services....
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq genetic testing services for the VA's Veterans Integrated Service Network (VISN) 22. The $366,000 contract will support thyroid cancer screening and diagnosis programs at VA healthcare facilities in California, New Mexico, Arizona, and other regional locations. The original solicitation was a...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 7, awarded a $607.5K firm fixed-price purchase order to Cytopath Biopsy Lab Inc. (doing business as Cblpath) for thyroid molecular testing services at the Atlanta VA Medical Center in Decatur, Georgia. The contract, awarded on May 1, 2024, with a completion date of April 30, 2029, represents a sole source procurement for the company's proprietary ThyroSeq v3 Genomic Classifier, which analyzes genetic mutations in...
- This is a firm fixed price purchase order contract awarded by the Veterans Integrated Service Network 6 (VISN 6), a civilian agency within the Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract is for the provision of ThyroSeq genomic classifier tests, which are specialized molecular diagnostic tests used to evaluate thyroid cancer risk. The contract has a ceiling value of $104,000.00 and a period of performance through October 31, 2024....
- This is a sole-source, firm-fixed-price contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 10 to Cytopath Biopsy Lab Inc., operating as Cblpath, to provide the ThyroSeq v3 Genomic Classifier molecular diagnostic testing service. The $386,785.00 contract has a base year plus four one-year option years and supports thyroid cancer screening and diagnosis for the Richard L. Roudebush VA Medical Center in Indianapolis, Indiana. Cblpath is a...